Redag Crop Protection appoints head of biology

Redag Crop Protection appoints head of biology

Innovative agrochemical company, Redag Crop Protection has appointed Dr Mikael Courbot to the key role of head of biology. Dr Courbot joins from multi-national agribusiness Syngenta, where he spent nine years working across sites in Switzerland and the UK. His areas of expertise include mechanisms of heavy metal transport and homeostasis in fungi and plants, in depth knowledge on abiotic stresses, along with the development of screening platforms.

He said: “I’m delighted to join Redag Crop Protection at what it is clearly a very exciting time for the company. The chance to work for a company that is fast-developing a reputation across Europe as being at the forefront of addressing the agrochemical innovation gap appealed greatly to me. The facilities at Alderley Park were also a major draw. They are genuinely world-class and there is a real sense of energy generated by the multiple companies in co-habitation at the site.”

See the article in full at ManchesterEveningNews.co.uk

Important information

This information is of a general nature and does not constitute an offer to provide services.

The opinions and conclusions given here are those of Seneca Partners and are subject to change without notice.

The value of investments and/or any income arising from them may fluctuate.

Past performance is not necessarily a guide to future performance.

Important notice

The products and services shown on this website place capital at risk. Investors may receive less in returns than they have invested. Investments may not allow for capital to be withdrawn on demand. If an investment provides tax relief then this relief is subject to change and is dependant on personal circumstances. Any reference to past performance or forecasted performance is not a reliable indicator of future performance.

Seneca Partners recommends that any investor seeks specialised financial and/or tax advice before investing. Seneca Partners does not provide advice and the information on this website, including but not limited to news, should not be construed as such.

Please confirm that you understand this warning and wish to proceed.